Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Deutetrabenazine metabolite M4 is believed to be related to its effect as a reversible depletion of monoamines from nerve terminals. The major circulating metabolites of Deutetrabenazine, are reversible inhibitors of VMAT2, resulting in decreased uptake of monoamines into synaptic vesicles and depletion of monoamine stores.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
100 mg | Inquiry | Inquiry | |
500 mg | Inquiry | Inquiry |
Description | Deutetrabenazine metabolite M4 is believed to be related to its effect as a reversible depletion of monoamines from nerve terminals. The major circulating metabolites of Deutetrabenazine, are reversible inhibitors of VMAT2, resulting in decreased uptake of monoamines into synaptic vesicles and depletion of monoamine stores. |
Synonyms | SD-1018, Deuterated monohydroxy tetrabenazine, D6-tetrabenazine metabolite M4 |
Molecular Weight | 339.46 |
Formula | C19H21D6NO4 |
CAS No. | 1688661-95-1 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Deutetrabenazine metabolite M4 1688661-95-1 SD 1018 SD-1018 Deuterated monohydroxy tetrabenazine SD1018 D6-tetrabenazine metabolite M4 Deutetrabenazine metabolite M-4 inhibitor inhibit